SPASTICITY PATTERNS OF HAND MUSCLES AND BOTULINUM TOXIN THERAPY APPLICATION IN PATIENTS WITH CEREBRAL PALSY WITH UPPER LIMB INVOLVEMENT

Botulinum toxin therapy is an effective and safe method of treatment of local spasticity in patients with cerebral palsy (CP). Calculation of botulinum toxin A (BTA) dosage based on the spasticity patterns and functional capabilities of the patient proved effective for the hypertonic lower limb muscle spasm treatment and is being applied to BTA injections in hand muscles more often. The article presents contemporary scientific data and results of the original study of BTA injections efficacy for pathologic tension reduction in hand muscles of 52 patients with CP. The authors give detailed description of the upper limb spasticity patterns, their frequency and role in the pathological movement pattern formation. The authors propose BTA dosage calculation for the functional segments of upper limbs, which allows minimizing the total amount of the administered drug and avoiding excessive weakness. The authors have also conducted a follow-up analysis of changes in hand muscle tone for the period of 6 months after the first BTA injection, compared results of botulinum toxin therapy at various clinical forms of CP and given recommendations on the optimum duration of the follow-up period.

1. Koman L. A., Mooney J. F. 3rd, Smith B., Goodman A., Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J. Pediatr. Orthop. 1993; 13 (4): 489–95.

2. Berweck S., Kirschner J., Heinen F. Therapy with botulinum toxin. In: Paediatric Neurology. Theory and practice (eds. Panteliadis C. P., Korinthenberg R.). Stuttgart; New York: Thieme. 2005. P. 925–951.

3. Delgado M. R., Hirtz D., Aisen M., Ashwal S., Fehlings D. L., McLaughlin J., Morrison L. A., Shrader M. W., Tilton A., Vargus-Adams J. Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010; 74 (4): 336–43.

4. Fehlings D., Novak I., Berweck S., Hoare B., Stott N. S., Russo R. N. Botulinum toxin assessment, intervention and followup for paediatric upper limb hypertonicity: international consensus statement. Eur. J. Neurol. 2010; 17 (Suppl. 2): 38–56.

5. Heinen F., Desloovere K., Schroeder A. S., Berweck S., Borggraefe I., van Campenhout A., Andersen G. L., Aydin R., Becher J. G., Bernert G., Caballero I. M., Carr L., Valayer E. C., Desiato M. T., Fairhurst C., Filipetti P., Hassink R. I., Hustedt U., Jozwiak M., Kocer S. I., Kolanowski E., Krageloh-Mann I., Kutlay S., Maenpaa H., Mall V., McArthur P., Morel E., Papavassiliou A., Pascual-Pascual I., Pedersen S. A., Plasschaert F. S., van der Ploeg I., Remy- Neris O., Renders A., Di Rosa G., Steinlin M., Tedroff K., Valls J. V., Viehweger E., Molenaers G. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur. J. Paediatr. Neurol. 2010; 14 (1): 45–66.

6. Hoare B. J., Wallen M. A., Imms C., Villanueva E., Rawicki H. B., Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst. Rev. 2010; 1.

7. The official electronic resource of public health system in Australia Available at: http://www.medicareaustralia.gov.au/provider/pbs/drugs1/botulinum.jsp.

8. Sakzewski L., Ziviani J., Boyd R. Systematic review and metaanalysis of therapeutic management of upper-limb dysfunction in children with congenital hemiplegia. Pediatrics. 2009; 123 (6): 1111–22.

9. Eliasson A. C., Burtner P. Improving Hand Function in Children with Cerebral Palsy. Mac Keith Press, 1 ed. 2008.

10. Eliasson A. C., Krumlinde-Sundholm L., Rosblad B., Beckung E., Arner M., Ohrvall A. M., Rosenbaum P. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev. Med. Child. Neurol. 2006; 48 (7): 549–54.

11. Lam K., Lau K. K., So K. K., Tam C. K., Wu Y. M., Cheung G., Liang K. S., Yeung K. M., Lam K. Y., Yui S., Leung C. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study. J. Am. Med. Dir. Assoc. 2012; 13 (5): 477–84.

12. Palisano R., Rosenbaum P., Walter S., Russell D., Wood E., Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child. Neurol. 1997; 39 (4): 214–23.

13. Rodda J., Graham H. K. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur. J. Neurol. 2001; 8 (Suppl. 5): 98–108.

14. Miller F. Cerebral Palsy. New York: Springer Science. 2005. 1055 p.

15. Holmstrom L., Vollmer B., Tedroff K., Islam M., Persson J. K., Kits A., Forssberg H., Eliasson A. C. Hand function in relation to brain lesions and corticomotor-projection pattern in children with unilateral cerebral palsy. Dev. Med. Child. Neurol. 2010; 52 (2): 145–52.

16. Ferrari A., Cioni G. The Spastic Forms of Cerebral Palsy. Italia: Springer-Verlag. 2010.

17. Molenaers G., Desloovere K., Fabry G., De Cock P. The effects of quantitative gait assessment and botulinum toxin a on mus culoskeletal surgery in children with cerebral palsy. J. Bone Joint Surg. Am. 2006; 88 (1): 161–70.

18. Hustedt U. Botulinumtoxin bei spastischen Bewegungsstorungen. Ultraschallgestutzte Technik und Anwendung. KVM. 2010. pp. 13–15.

19. Umnov V. V., Novikov V. A. Travmatologiya i ortopediya Rossii = Traumatology and orthopedics in Russia. 2010; 1: 124–130.

20. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner. 1964; 192: 540–542.

21. Umnov V. V., Novikov V. A., Zvozil' A. V. Travmatologiya i ortopediya Rossii = Traumatology and orthopedics in Russia. 2011; 3: 137–145.

22. Heinen F., Molenaers G., Fairhurst C., Carr L. J., Desloovere K., Chaleat Valayer E., Morel E., Papavassiliou A. S., Tedroff K., Ignacio Pascual-Pascual S., Bernert G., Berweck S., Di Rosa G., Kolanowski E., Krageloh-Mann I. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur. J. Paediatr. Neurol. 2006; 10 (5–6): 215–25.

23. Molenaers G., Schorkhuber V., Fagard K., Van Campenhout A., De Cat J., Pauwels P., Ortibus E., De Cock P., Desloovere K. Longterm use of botulinum toxin type A in children with cerebral palsy: treatment consistency. Eur. J. Paediatr. Neurol. 2009; 13 (5): 421–429.

24. Mall V., Heinen F., Siebel A., Bertram C., Hafkemeyer U., Wissel J. Treatment of adductor spasticity with BTX-A in children with CP: А randomized, double-blind, placebocontrolled study. Dev. Med. Child Neurol. 2006; 48 (1): 10–13.

25. Baker R., Jasinski M., Maciag-Tymecka I., Michalowska-Mrozek J., Bonikowski M., Carr L. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose ranging study. Dev. Med. Child. Neurol. 2002; 44 (10): 666–675.

26. Semenova K. A., Mastyukova E. M., Smuglin M. Ya. Klinika i reabilitatsionnaya terapiya detskikh tserebral'nykh paralichei [Clinical Picture and Rehabilitation Therapy of Child Cerebral Palsy]. Moscow, Meditsina, 1973. 326 p.

27. Kislyakova E. A., Maslova N. N., Alimova I. L. Byulleten' sibirskoi meditsiny = Bulletin of Siberian medicine. 2008; 7 (3): 97–103.

28. Boyd R. N., Morris M. E., Graham H. K. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur. J. Neurol. 2001; 8 (Suppl. 5): 150–166.

29. Papavasiliou A. S., Nikaina I., Bouros P., Rizou I., Filiopoulos C. Botulinum toxin treatment in upper limb spasticity: treatment consistency. Eur. J. Paediatr. Neurol. 2012; 16 (3): 237–42.

30. Zmanovskaya V. A. Klinicheskie varianty spasticheskikh form detskogo tserebral'nogo paralicha i otsenka effektivnosti botulinoterapii. Avtoref. dis. … kand. med. nauk [Clinical Variants of Spastic Cerebral Palsy Forms and Evaluation of Botulinotherapy Effect. Author’s abstract]. Ekaterinburg, 2011. 156 p.

31. Shen J., Ma J., Lee C, Smith B. P., Smith T. L. How muscles recover from paresis and atrophy after inframusculas injections of botulinum toxin A: study in juvenile rats. Journal of orthopedic research. 2006; 24 (5): 1128–1135.

32. Corry I. S., Cosgrove A. P., Walsh E. G., McClean D., Graham H. K. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev. Med. Child Neurol. 1997; 39 (3): 185–93.

33. Fehlings D., Rang M., Glazier J., Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J. Pediatr. 2000; 137 (3): 331–337.

34. Kawamura A., Campbell K., Lam-Damji S., Fehlings D. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Dev. Med. Child Neurol. 2007; 49 (5): 331–337.

35. Russo R. N., Crotty M., Miller M. D., Murchland S., Flett P., Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics. 2007; 119 (5): 1149–1158.

36. Klochkova O. A., Kurenkov A. L., Mamed"yarov A. M., Namazova-Baranova L. S., Gevorkyan A. K., Karimova Kh. M. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2013; 10 (2): 80–86.

37. Schroeder A. S., Berweck S., Lee S. H., Heinen F. Botulinum toxin treatment of children with cerebral palsy — a short review of different injection techniques. Neurotox Res. 2006; 9 (2–3): 189–96.

38. Yang E. J., Rha D. W., Yoo J. K., Park E. S. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch. Phys Med. Rehabil. 2009; 90 (5): 741–4.

39. Berweck S., Feldkamp A., Francke A., Nehles J., Schwerin A., Heinen F. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics. 2002; 33 (4): 221–3.

40. Westhoff B., Seller K., Wild A., Jaeger M., Krauspe R. Ultrasoundguided botulinum toxin injection technique for the iliopsoas muscle. Dev. Med. Child Neurol. 2003; 45 (12): 829–32.

41. Py A. G., Zein Addeen G., Perrier Y., Carlier R. Y., Picard A. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Ann. Phys. Rehabil. Med. 2009; 52 (3): 215–23.